Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Virginia Commonwealth University
- Study ID
- NCT05720663
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Standard of care — OTHERParticipants will receive the standard of care for their condition
Study Details
Nonalcoholic Steatohepatitis (NASH) is a condition with increased amount of fat, inflammation and scarring in the liver. In compensated cirrhosis, the liver is coping with this damage and maintaining its important functions. Decompensation occurs when the liver becomes unable to perform all of its functions adequately. Variceal hemorrhage (bleeding from abnormal vessels in the liver called varices), Ascites (abnormal build-up of fluid in the abdomen), and Encephalopathy (brain confusion as a result of the liver not being able to get rid of toxic substances) are three symptoms of liver decompensation. The purpose of this research study is to investigate better ways to routinely monitor the condition of patients with NASH with compensated cirrhosis and to better pinpoint the development of decompensation in the livers of these patients.
Key Dates
- Start date
- Apr 19, 2023
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 240 participants (estimated)
Arms
- Arm: nonalcoholic steatohepatitis (NASH)Adult patients nonalcoholic steatohepatitis (NASH)
Primary Outcome Measure
Number of deaths [ Time Frame: Up to 2 years ]
Central Contacts
- Mohammad S Siddiqui, MD804-828-4060
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Manal F. Abdelmalek, MD (PRINCIPAL_INVESTIGATOR) |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | Mohammad Siddiqui, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
Related Studies
- Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNot Yet Recruiting · Keith Pereira, MD: · St Louis, Missouri
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)PHASE2 · Recruiting · University of Florida · Gainesville, Florida
- Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin ResistanceRecruiting · Stanford University · Stanford, California
- Metabolic Pathology of Pediatric NAFLDRecruiting · University of Oklahoma · Oklahoma City, Oklahoma